Monday, November 06, 2006

Canada OKs Novartis arthritis drug Prexige

This drug approval could very well be mentioned in the mainstream press, primarily because Prexige is in the same class as Vioxx and Bextra.

Prexige (lumiracoxib) is made by Novartis and is available in many countries throughout the world, but not the United States. If you want a bit of advance info, the prroduct information for Australian health professionals is located here and the Australian consumer package leaflet is linked here.

From Reuters:
Canada has approved use of Novartis's (NOVN.VX: Quote, Profile, Research) arthritis drug Prexige, the first such drug allowed after an investigation into potential heart problems linked to their use, a source familiar with the approval said on Monday.

Prexige is one of several COX-2 inhibitors, drugs that were originally designed to be safer long-term treatments than Aspirin or other analgesics for arthritis or other pain. ...more

No comments: